LICENSE AND DEVELOPMENT AGREEMENT by and between ATHENEX, INC. and ALMIRALL, S.A. and AQUA PHARMACEUTICALS LLCLicense and Development Agreement • December 15th, 2017 • Athenex, Inc. • Pharmaceutical preparations • England and Wales
THIS LICENSE AND DEVELOPMENT AGREEMENT (this “Agreement”) is made and entered into as of December 11, 2017 (“Execution Date”), by and between ATHENEX, INC., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 1001 Main Street, Suite 600, Buffalo, New York, United States (“Athenex”), ALMIRALL, S.A., a corporation organized and existing under the laws of Spain and having its principal office at Ronda del General Mitre 151, Barcelona 08022 – Spain (“Almirall”), and AQUA PHARMACEUTICALS LLC, a limited liability company organized and existing under the laws of the Commonwealth of Pennsylvania and having its principal office at 707 Eagleview Blvd, Suite 200, Exton PA 19341 (“Aqua”).
